Peanut allergy in Mexican children: what is the effect of age at first consumption?

Martín Bedolla Barajas1, Guadalupe Alcala-Padilla2, Jaime Morales Romero3

  • 1Allergy and Clinical Immunology Service. Hospital Civil de Guadalajara "Dr. Juan I. Menchaca". Guadalajara, Jalisco, Mexico.

Insights

Introducing peanuts later in childhood, after age two, significantly increases the risk of developing a peanut allergy. Early exposure appears protective against peanut allergies.

Area of Science:

  • Pediatric Allergy and Immunology
  • Clinical Nutrition
  • Epidemiology of Allergic Diseases

Background:

  • Early introduction of solid foods is linked to increased food allergy risk in children.
  • Peanut allergy is a common and potentially severe childhood allergic condition.
  • Understanding the timing of peanut introduction is crucial for allergy prevention strategies.

Purpose of the Study:

  • To investigate the association between the age of peanut introduction and the development of peanut allergy.
  • To identify risk factors for peanut allergy in children with existing allergic conditions.
  • To evaluate the impact of early versus late peanut consumption on allergy development.

Main Methods:

  • Prospective study involving 300 children with allergic rhinitis and asthma.
  • Data collection included clinical history, peanut skin tests, parental interviews on eating habits, and open oral food challenges (OOFC).
  • Statistical analysis, including multivariate analysis, was used to determine risk factors for peanut allergy.

Main Results:

  • The median age of first peanut exposure was significantly higher in children with peanut allergies (2 years) compared to those without (1 year).
  • Late introduction of peanuts (after age ≥2 years) was identified as a significant risk factor for developing peanut allergy (OR=8.0, p=0.026).
  • Children subjected to OOFC with a history of allergy or positive skin test showed a clear link between late consumption and allergy.

Conclusions:

  • Late introduction of peanuts to a child's diet increases the risk of developing a peanut allergy.
  • Early exposure to peanuts may play a protective role in preventing peanut allergy.
  • These findings have implications for infant feeding guidelines and allergy prevention.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
322
Allergic Reactions02:06

Allergic Reactions

Overview
33.4K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
678
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
149
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.3K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
799